Skip to main content

Table 3 Between-group analysis of baseline ASCS (T0) as well as improvement in ASCS after treatment (T1 – T0) and at follow-up (T2 – T0)

From: Adaptive conjunctive cognitive training (ACCT) in virtual reality for chronic stroke patients: a randomized controlled pilot trial

ASCSEG (n = 16)CG (n = 14)p
 Mean (SD) – Median [2.5th – 97.5th percentile]Ws
Attention
 T0-0.35 (0.88) – -0.28 [-2.11 – 1.22]-0.16 (0.83) – 0.11 [-1.78 – 0.89].39
 T1 – T00.22 (0.39) – 0.17 [-0.44 – 0.89]0.17 (0.50) – 0.17 [-0.78 – 1.00].80
 T2 – T00.41 (0.46) – 0.44 [-0.44 – 1.33]0.19 (0.32) – 0.17 [-0.44 – 0.78].21
Memory
 T0-0.76 (0.69) – -0.57 [-2.27 – 0.05]-0.72 (0.82) – -0.54 [-2.38 – 0.40].85
 T1 – T00.21 (0.50) – 0.23 [-0.70 – 1.22]0.20 (0.31) – 0.10 [-0.30 – 0.76].82
 T2 – T00.33 (0.65) – 0.47 [-0.73 – 1.71]0.34 (0.51) – 0.34 [-0.47 – 1.29].79
EF
 T0-0.34 (1.01) – -0.34 [-1.64 – 1.32]-0.45 (1.38) – -0.27 [-2.67 – 1.79].92
 T1 – T00.05 (0.61) – 0.04 [-1.55 – 0.96]0.17 (0.54) – 0.17 [-0.30 – 0.76].57
 T2 – T00.19 (0.62) – 0.22 [-0.85 – 1.55]0.17 (0.56) – 0.18 [-1.25 – 1.00].79
SA
 T0-2.88 (6.57) – -0.39 [-25.17 – 0.50]-0.58 (1.44) – 0.05 [-3.93 – 0.50].45
 T1 – T02.21 (6.55) – 0.88 [-6.19 – 24.78]0.38 (1.08) – 0.00 [-0.88 – 2.65].24
 T2 – T03.21 (6.57) – 0.88 [-0.88 – 25.66]0.06 (1.95) – 0.00 [-5.31 – 2.65].10
GCF
 T0-0.56 (0.79) – -0.44 [-1.92 – 0.39]-0.38 (0.90) – 0.00 [-2.00 – 0.69].49
 T1 – T00.36 (0.36) – 0.34 [-0.06 – 0.90]0.21 (0.45) – 0.13 [-0.31 – 1.27].12
 T2 – T00.44 (0.42) – 0.54 [-0.56 – 1.17]0.22 (0.37) – 0.14 [-0.22 – 0.90].12
  1. The differences at baseline and in improvement from baseline at T1 and T2 between groups were evaluated using the Wilcoxon rank-sum test Ws. The table shows the p-values (p) of the comparisons. ASCS average standardized composite score, CG control group, GCF generalized cognitive functioning, EF executive functioning, EG experimental group, LOCF last observation carried forward, SA spatial awareness